JWCA
GSK icon

J.W. Cole Advisors’s GSK GSK Stock Holding History

J.W. Cole Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$654K Sell
12,475
-875
-7% -$46.3K 0.01% 916
2026
Q1 		$737K Sell
13,350
-1,768
-12% -$95.8K 0.02% 435
2025
Q4 		$716K Sell
15,118
-442
-3% -$20.6K 0.02% 762
2025
Q3 		$672K Buy
15,560
+1,448
+10% +$56.6K 0.01% 880
2025
Q2 		$542K Buy
14,112
+2,344
+20% +$89.6K 0.01% 887
2025
Q1 		$456K Buy
+11,768
New +$431K 0.01% 793
2024
Q4 		– Sell
-5,905
Closed -$241K – 977
2024
Q3 		$241K Buy
5,905
+3
+0.1% +$123 0.01% 840
2024
Q2 		$227K Sell
5,902
-195
-3% -$8.2K 0.01% 799
2024
Q1 		$261K Buy
6,097
+271
+5% +$11.2K 0.01% 741
2023
Q4 		$216K Buy
5,826
+142
+2% +$5.1K 0.01% 741
2023
Q3 		$206K Sell
5,684
-348
-6% -$12.4K 0.02% 676
2023
Q2 		$215K Sell
6,032
-468
-7% -$16.8K 0.02% 680
2023
Q1 		$231K Buy
+6,500
New +$227K 0.02% 684
2022
Q4 		– Sell
-9,795
Closed -$288K – 751
2022
Q3 		$288K Buy
9,795
+3,641
+59% +$138K 0.02% 553
2022
Q2 		$335K Sell
6,154
-2,365
-28% -$131K 0.03% 517
2022
Q1 		$464K Buy
8,519
+1,581
+23% +$85.9K 0.03% 474
2021
Q4 		$382K Buy
6,938
+1,248
+22% +$64.9K 0.02% 563
2021
Q3 		$272K Sell
5,690
-662
-10% -$33.3K 0.02% 379
2021
Q2 		$316K Buy
6,352
+131
+2% +$6.29K 0.02% 569
2021
Q1 		$278K Buy
6,221
+743
+14% +$33.7K 0.03% 537
2020
Q4 		$252K Sell
5,478
-10,052
-65% -$462K 0.03% 525
2020
Q3 		$731K Sell
15,530
-1,718
-10% -$86.1K 0.06% 328
2020
Q2 		$879K Buy
17,248
+6,970
+68% +$358K 0.13% 174
2020
Q1 		$487K Sell
10,278
-6,747
-40% -$360K 0.94% 31
2019
Q4 		$1M Buy
+17,025
New +$947K 0.13% 186

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM

J.W. Cole Advisors's GSK Position: Q2 2026 in Review

J.W. Cole Advisors reduced its GSK (GSK) stake by 6.6% in Q2 2026, selling an estimated $46.3K and leaving 12,475 shares worth $654K. The position accounts for 0.01% of the portfolio, ranked #916.

J.W. Cole Advisors first reported a position in GSK in Q4 2019 and has held it in 25 quarters since. The position peaked at $1M in Q4 2019. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • J.W. Cole Advisors held 12,475 shares of GSK worth $654K as of Q2 2026.
  • J.W. Cole Advisors sold 875 GSK shares in Q2 2026, an estimated $46.3K.
  • GSK made up 0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #916 holding.
  • J.W. Cole Advisors first reported a position in GSK in Q4 2019 and has held it in 25 quarters since.
  • J.W. Cole Advisors's GSK position peaked at $1M in Q4 2019.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.